PAX genes in cancer; friends or foes?

Frontiers in Genetics

Volumn 3, Issue JAN, 2012, Pages

  Li, Caiyun G ^a   Eccles, Michael R ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cancer; Cell cycle; Differentiation; PAX; Proliferation; Stem cell

Indexed keywords

EID: 84875216309     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00006     Document Type: Review

References (114)

1. Adams, B., Dorfler, P., Aguzzi, A., Kozmik, Z., Urbanek, P., Maurer-Fogy, I., and Busslinger, M. (1992). Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6, 1589-1607.
2. Bai, S. W., Li, B., Zhang, H., Jonas, J. B., Zhao, B. W., Shen, L., and Wang, Y. C. (2011). Pax6 regulates proliferation and apoptosis of human retinoblastoma cells. Invest. Ophthalmol. Vis. Sci. 52, 4560-4570.
3. Baumann Kubetzko, F. B., Di Paolo, C., Maag, C., Meier, R., Schafer, B. W., Betts, D. R., Stahel, R. A., and Himmelmann, A. (2004). The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line. Carcinogenesis 25, 1839-1846.
4. Baumer, N., Marquardt, T., Stoykova, A., Spieler, D., Treichel, D., Ashery-Padan, R., and Gruss, P. (2003). Retinal pigmented epithelium determination requires the redundant activities of Pax2 and Pax6. Development 130, 2903-2915.
5. Bennicelli, J. L., Advani, S., Schafer, B. W., and Barr, F. G. (1999). PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma. Oncogene 18, 4348-4356.
6. Berton, T. R., Mitchell, D. L., Guo, R., and Johnson, D. G. (2005). Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation. Oncogene 24, 2449-2460.
7. Bowen, N. J., Logani, S., Dickerson, E. B., Kapa, L. B., Akhtar, M., Benigno, B. B., and Mcdonald, J. F. (2007). Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol. Oncol. 104, 331-337.
8. Brun, T., Duhamel, D. L., Hu He, K. H., Wollheim, C. B., and Gauthier, B. R. (2007). The transcription factor PAX4 acts as a survival gene in INS-1E insulinoma cells. Oncogene 26, 4261-4271.
9. Brun, T., Franklin, I., St-Onge, L., Biason-Lauber, A., Schoenle, E. J., Wollheim, C. B., and Gauthier, B. R. (2004). The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets. J. Cell Biol. 167, 1123-1135.
10. Buckingham, M., and Relaix, F. (2007). The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu. Rev. Cell Dev. Biol. 23, 645-673.
11. Buttiglieri, S., Deregibus, M. C., Bravo, S., Cassoni, P., Chiarle, R., Bussolati, B., and Camussi, G. (2004). Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells. J. Biol. Chem. 279, 4136-4143.
12. Chang, J. Y., Hu, Y., Siegel, E., Stanley, L., and Zhou, Y. H. (2007). PAX6 increases glioma cell susceptibility to detachment and oxidative stress. J. Neurooncol. 84, 9-19.
13. Chen, Q., Degraff, D. J., and Sikes, R. A. (2010). The developmental expression profile of PAX2 in the murine prostate. Prostate 70, 654-665.
14. Chen, Y. J., Campbell, H. G., Wiles, A. K., Eccles, M. R., Reddel, R. R., Braithwaite, A. W., and Royds, J. A. (2008). PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma. Cancer Res. 68, 5724-5732.
15. Cheung, H. W., Cowley, G. S., Weir, B. A., Boehm, J. S., Rusin, S., Scott, J. A., East, A., Ali, L. D., Lizotte, P. H., Wong, T. C., Jiang, G., Hsiao, J., Mermel, C. H., Getz, G., Barretina, J., Gopal, S., Tomayo, P., Gould, J., Tsherniak, A., Stransky, N., Luo, B., Ren, Y., Drapkin, R., Bhatia, S. N., Meslrov, J. P., Garraway, L. A., Meyerson, M., Lander, E. S., Root, D. E., and Hahn, W. C. (2011). Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 108, 12372-12377.
16. Chi, N., and Epstein, J. A. (2002). Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 18, 41-47.
17. Chu, Y., Hughes, S., and Chan-Ling, T. (2001). Differentiation and migration of astrocyte precursor cells and astrocytes in human fetal retina: relevance to optic nerve coloboma. FASEB J. 15, 2013-2015.
18. Cohen, T., Loutochin, O., Amin, M., Capolicchio, J. P., Goodyer, P., and Jednak, R. (2007). PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death. Am. J. Physiol. Renal Physiol. 292, F1267-F1273.
19. De Felice, M., and Di Lauro, R. (2011). Minireview: intrinsic and extrinsic factors in thyroid gland development: an update. Endocrinology 152, 2948-2956.
20. Dimri, G. P., Itahana, K., Acosta, M., and Campisi, J. (2000). Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol. Cell. Biol. 20, 273-285.
21. Doberstein, K., Pfeilschifter, J., and Gutwein, P. (2011). The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma. Carcinogenesis. 32, 1713-1723.
22. Epstein, D. J., Vekemans, M., and Gros, P. (1991). Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67, 767-774.
23. Favor, J., Sandulache, R., Neuhauser-Klaus, A., Pretsch, W., Chatterjee, B., Senft, E., Wurst, W., Blanquet, V., Grimes, P., Sporle, R., and Schughart, K. (1996). The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney. Proc. Natl. Acad. Sci. U.S.A. 93, 13870-13875.
24. Ferretti, E., Arturi, F., Mattei, T., Scipioni, A., Tell, G., Tosi, E., Presta, I., Morisi, R., Lacroix, L., Gulino, A., Russo, D., Damante, G., and Filetti, S. (2005). Expression, regulation, and function of paired-box gene 8 in the human placenta and placental cancer cell lines. Endocrinology 146, 4009-4015.
25. Frascella, E., Toffolatti, L., and Rosolen, A. (1998). Normal and rearranged PAX3 expression in human rhabdomyosarcoma. Cancer Genet. Cytogenet. 102, 104-109.
26. Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J. III, Emanuel, B. S., Rovera, G., and Barr, F. G. (1993). Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5, 230-235.
27. Gerber, J. K., Richter, T., Kremmer, E., Adamski, J., Hofler, H., Balling, R., and Peters, H. (2002). Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus. J. Pathol. 197, 293-297.
28. Guo, Z., Packard, A., Krolewski, R. C., Harris, M. T., Manglapus, G. L., and Schwob, J. E. (2010). Expression of pax6 and sox2 in adult olfactory epithelium. J. Comp. Neurol. 518, 4395-4418.
29. Hanna, J., Markoulaki, S., Schorderet, P., Carey, B. W., Beard, C., Wernig, M., Creyghton, M. P., Steine, E. J., Cassady, J. P., Foreman, R., Lengner, C. J., Dausman, J. A., and Jaenisch, R. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133, 250-264.
30. Hata, S., Hamada, J., Maeda, K., Murai, T., Tada, M., Furukawa, H., Tsutsumida, A., Saito, A., Yamamoto, Y., and Moriuchi, T. (2008). PAX4 has the potential to function as a tumor suppressor in human melanoma. Int. J. Oncol. 33, 1065-1071.
31. He, S., Li, C. G., Slobbe, L., Glover, A., Marshall, E., Baguley, B. C., and Eccles, M. R. (2011). PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression. Melanoma Res. 21, 24-34.
32. He, S., Yoon, H. S., Suh, B. J., and Eccles, M. R. (2010). PAX3 is extensively expressed in benign and malignant tissues of the melanocytic lineage in humans. J. Invest. Dermatol. 130, 1465-1468.
33. Hellwinkel, O. J., Kedia, M., Isbarn, H., Budaus, L., and Friedrich, M. G. (2008). Methylation of the TPEF-and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours. BJU Int. 101, 753-757.
34. Heltemes-Harris, L. M., Willette, M. J., Ramsey, L. B., Qiu, Y. H., Neeley, E. S., Zhang, N., Thomas, D. A., Koeuth, T., Baechler, E. C., Kornblau, S. M., and Farrar, M. A. (2011). Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia. J. Exp. Med. 208, 1135-1149.
35. Herlitz, L. C., Tong, G. X., Hamele-Bena, D., and Greenebaum, E. (2008). Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining. Diagn. Cytopathol. 36, 47-49.
36. Hibbs, K., Skubitz, K. M., Pambuccian, S. E., Casey, R. C., Burleson, K. M., Oegema, T. R. Jr., Thiele, J. J., Grindle, S. M., Bliss, R. L., and Skubitz, A. P. (2004). Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am. J. Pathol. 165, 397-414.
37. Hill, R. E., Favor, J., Hogan, B. L., Ton, C. C., Saunders, G. F., Hanson, I. M., Prosser, J., Jordan, T., Hastie, N. D., and Van Heyningen, V. (1991). Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature 354, 522-525.
38. Huang, B., Pi, L., Chen, C., Yuan, F., Zhou, Q., Teng, J., and Jiang, T. (2011). WT1 and Pax2 re-expression is required for epithelial-mesenchymal transition in 5/6 nephrectomized rats and cultured kidney tubular epithelial cells. Cells Tissues Organs (Print). doi:10.1159/000327530. [Epub ahead of print].
39. Hueber, P. A., Waters, P., Clark, P., Eccles, M., and Goodyer, P. (2006). PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells. Kidney Int. 69, 1139-1145.
40. Hurtado, A., Holmes, K. A., Geistlinger, T. R., Hutcheson, I. R., Nicholson, R. I., Brown, M., Jiang, J., Howat, W. J., Ali, S., and Carroll, J. S. (2008). Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 456, 663-666.
41. Imgrund, M., Grone, E., Grone, H. J., Kretzler, M., Holzman, L., Schlondorff, D., and Rothenpieler, U. W. (1999). Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice 1. Kidney Int. 56, 1423-1431.
42. Jackson, I. J., and Raymond, S. (1994). Manifestations of microphthalmia. Nat. Genet. 8, 209-210.
43. Kendall, J., Liu, Q., Bakleh, A., Krasnitz, A., Nguyen, K. C., Lakshmi, B., Gerald, W. L., Powers, S., and Mu, D. (2007). Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 16663-16668.
44. Khoubehi, B., Kessling, A. M., Adshead, J. M., Smith, G. L., Smith, R. D., and Ogden, C. W. (2001). Expression of the developmental and oncogenic PAX2 gene in human prostate cancer. J. Urol. 165, 2115-2120.
45. Kozmik, Z., Sure, U., Ruedi, D., Busslinger, M., and Aguzzi, A. (1995). Deregulated expression of PAX5 in medulloblastoma. Proc. Natl. Acad. Sci. U.S.A. 92, 5709-5713.
46. Krenacs, L., Himmelmann, A. W., Quintanilla-Martinez, L., Fest, T., Riva, A., Wellmann, A., Bagdi, E., Kehrl, J. H., Jaffe, E. S., and Raffeld, M. (1998). Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Blood 92, 1308-1316.
47. Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C. J., Mueller, E., Spiegelman, B. M., and Fletcher, J. A. (2000). PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 289, 1357-1360.
48. Kubic, J. D., Young, K. P., Plummer, R. S., Ludvik, A. E., and Lang, D. (2008). Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res. 21, 627-645.
49. Lai, H. C., Lin, Y. W., Huang, T. H., Yan, P., Huang, R. L., Wang, H. C., Liu, J., Chan, M. W., Chu, T. Y., Sun, C. A., Chang, C. C., and Yu, M. H. (2008). Identification of novel DNA methylation markers in cervical cancer. Int. J. Cancer 123, 161-167.
50. Lang, D., Lu, M. M., Huang, L., Engleka, K. A., Zhang, M., Chu, E. Y., Lipner, S., Skoultchi, A., Millar, S. E., and Epstein, J. A. (2005). Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433, 884-887.
51. Lang, D., Mascarenhas, J. B., Powell, S. K., Halegoua, J., Nelson, M., and Ruggeri, B. A. (2008). PAX6 is expressed in pancreatic adenocarcinoma and is downregulated during induction of terminal differentiation. Mol. Carcinog. 47, 148-156.
52. Lee, J. C., Sharma, M., Lee, Y. H., Lee, N. H., Kim, S. Y., Yun, J. S., Nam, S. Y., Hwang, P. H., Jhee, E. C., and Yi, H. K. (2008). Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c-myb. Cell Biochem. Funct. 26, 892-899.
53. Leiper, L. J., Ou, J., Walczysko, P., Kucerova, R., Lavery, D. N., West, J. D., and Collinson, J. M. (2009). Control of patterns of corneal innervation by Pax6. Invest. Ophthalmol. Vis. Sci. 50, 1122-1128.
54. Li, C. G., Nyman, J. E., Braithwaite, A. W., and Eccles, M. R. (2011a). PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein. Oncogene 30, 4824-4834.
55. Li, L., Li, B., Zhang, H., Bai, S., Wang, Y., Zhao, B., and Jonas, J. B. (2011b). Lentiviral vector-mediated PAX6 overexpression promotes growth and inhibits apoptosis of human retinoblastoma cells. Invest. Ophthalmol. Vis. Sci. 52, 8393-8400.
56. Little, M. H., and Bertram, J. F. (2009). Is there such a thing as a renal stem cell? J. Am. Soc. Nephrol. 20, 2112-2117.
57. Liu, W., Li, X., Chu, E. S., Go, M. Y., Xu, L., Zhao, G., Li, L., Dai, N., Si, J., Tao, Q., Sung, J. J., and Yu, J. (2011). Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology 53, 843-853.
58. Lu, J., Li, G., Lan, M. S., Zhang, S., Fan, W., Wang, H., and Lu, D. (2007). Pax4 paired domain mediates direct protein transduction into mammalian cells. Endocrinology 148, 5558-5565.
59. Luu, V. D., Boysen, G., Struckmann, K., Casagrande, S., Von Teichman, A., Wild, P. J., Sulser, T., Schraml, P., and Moch, H. (2009). Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clin. Cancer Res. 15, 3297-3304.
60. Maeshima, A., Maeshima, K., Nojima, Y., and Kojima, I. (2002). Involvement of Pax-2 in the action of activin A on tubular cell regeneration. J. Am. Soc. Nephrol. 13, 2850-2859.
61. Mascarenhas, J. B., Young, K. P., Littlejohn, E. L., Yoo, B. K., Salgia, R., and Lang, D. (2009). PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene. J. Biol. Chem. 284, 27524-27532.
62. Maulbecker, C. C., and Gruss, P. (1993). The oncogenic potential of Pax genes. EMBO J. 12, 2361-2367.
63. Mayes, D. A., Hu, Y., Teng, Y., Siegel, E., Wu, X., Panda, K., Tan, F., Yung, W. K., and Zhou, Y. H. (2006). PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Cancer Res. 66, 9809-9817.
64. Medic, S., and Ziman, M. (2010). PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas). PLoS ONE 5, e9977. doi:10.1371/journal.pone.0009977
65. Miller, D. J. (1999). What the cnidaria tell us about Pax gene evolution. Zool. Stud. 38, 367-372.
66. Mittag, J., Winterhager, E., Bauer, K., and Grummer, R. (2007). Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. Endocrinology 148, 719-725.
67. Miyamoto, T., Kakizawa, T., Ichikawa, K., Nishio, S., Kajikawa, S., and Hashizume, K. (2001). Expression of dominant negative form of PAX4 in human insulinoma. Biochem. Biophys. Res. Commun. 282, 34-40.
68. Moelans, C. B., Verschuur-Maes, A. H., and Van Diest, P. J. (2011). Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer. J. Pathol. 225, 222-231.
69. Monte, N. M., Webster, K. A., Neuberg, D., Dressler, G. R., and Mutter, G. L. (2010). Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Res. 70, 6225-6232.
70. Muratovska, A., Zhou, C., He, S., Goodyer, P., and Eccles, M. R. (2003). Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22, 7989-7997.
71. Nakamura, H. (2001). Regionalization of the optic tectum: combinations of gene expression that define the tectum. Trends. Neurosci. 24, 32-39.
72. Nutt, S. L., Urbanek, P., Rolink, A., and Busslinger, M. (1997). Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11, 476-491.
73. Ou, J., Lowes, C., and Collinson, J. M. (2010). Cytoskeletal and cell adhesion defects in wounded and Pax6± corneal epithelia. Invest. Ophthalmol. Vis. Sci. 51, 1415-1423.
74. Ozcan, A., Shen, S. S., Hamilton, C., Anjana, K., Coffey, D., Krishnan, B., and Truong, L. D. (2011). PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod. Pathol. 24, 751-764.
75. Park, C., Lee, I., and Kang, W. K. (2006). E2F-1 is a critical modulator of cellular senescence in human cancer. Int. J. Mol. Med. 17, 715-720.
76. Peters, H., Doll, U., and Niessing, J. (1995). Differential expression of the chicken Pax-1 and Pax-9 gene: in situ hybridization and immunohistochemical analysis. Dev. Dyn. 203, 1-16.
77. Peters, H., Schuster, G., Neubuser, A., Richter, T., Hofler, H., and Balling, R. (1997). Isolation of the Pax9 cDNA from adult human esophagus. Mamm. Genome 8, 62-64.
78. Pinto, G. R., Clara, C. A., Santos, M. J., Almeida, J. R., Burbano, R. R., Rey, J. A., and Casartelli, C. (2007). Mutation analysis of gene PAX6 in human gliomas. Genet. Mol. Res. 6, 1019-1025.
79. Proulx, M., Cayer, M. P., Drouin, M., Laroche, A., and Jung, D. (2010). Overexpression of PAX5 induces apoptosis in multiple myeloma cells. Int. J. Hematol. 92, 451-462.
80. Qin, X. Q., Livingston, D. M., Kaelin, W. G. Jr., and Adams, P. D. (1994). Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. U.S.A. 91, 10918-10922.
81. Ramaesh, T., Ramaesh, K., Leask, R., Springbett, A., Riley, S. C., Dhillon, B., and West, J. D. (2006). Increased apoptosis and abnormal wound-healing responses in the heterozygous Pax6± mouse cornea. Invest. Ophthalmol. Vis. Sci. 47, 1911-1917.
82. Ramaesh, T., Ramaesh, K., Martin Collinson, J., Chanas, S. A., Dhillon, B., and West, J. D. (2005). Developmental and cellular factors underlying corneal epithelial dysgenesis in the Pax6± mouse model of aniridia. Exp. Eye Res. 81, 224-235.
83. Rath, M. F., Bailey, M. J., Kim, J. S., Coon, S. L., Klein, D. C., and Moller, M. (2009a). Developmental and daily expression of the Pax4 and Pax6 homeobox genes in the rat retina: localization of Pax4 in photoreceptor cells. J. Neurochem. 108, 285-294.
84. Rath, M. F., Bailey, M. J., Kim, J. S., Ho, A. K., Gaildrat, P., Coon, S. L., Moller, M., and Klein, D. C. (2009b). Developmental and diurnal dynamics of Pax4 expression in the mammalian pineal gland: nocturnal down-regulation is mediated by adrenergic-cyclic adenosine 3′,5′-monophosphate signaling. Endocrinology 150, 803-811.
85. Relaix, F., Montarras, D., Zaffran, S., Gayraud-Morel, B., Rocancourt, D., Tajbakhsh, S., Mansouri, A., Cumano, A., and Buckingham, M. (2006). Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J. Cell Biol. 172, 91-102.
86. Rieck, S., White, P., Schug, J., Fox, A. J., Smirnova, O., Gao, N., Gupta, R. K., Wang, Z. V., Scherer, P. E., Keller, M. P., Attie, A. D., and Kaestner, K. H. (2009). The transcriptional response of the islet to pregnancy in mice. Mol. Endocrinol. 23, 1702-1712.
87. Ritz-Laser, B., Estreicher, A., Gauthier, B., and Philippe, J. (2000). The paired homeodomain transcription factor Pax-2 is expressed in the endocrine pancreas and transactivates the glucagon gene promoter. J. Biol. Chem. 275, 32708-32715.
88. Robson, E. J., He, S. J., and Eccles, M. R. (2006). A PANorama of PAX genes in cancer and development. Nat. Rev. Cancer 6, 52-62.
89. Roh, M. H., Yassin, Y., Miron, A., Mehra, K. K., Mehrad, M., Monte, N. M., Mutter, G. L., Nucci, M. R., Ning, G., Mckeon, F. D., Hirsch, M. S., Wa, X., and Crum, C. P. (2010). High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod. Pathol. 23, 1316-1324.
90. Salem, C. E., Markl, I. D., Bender, C. M., Gonzales, F. A., Jones, P. A., and Liang, G. (2000). PAX6 methylation and ectopic expression in human tumor cells. Int. J. Cancer 87, 179-185.
91. Sansom, S. N., Griffiths, D. S., Faedo, A., Kleinjan, D. J., Ruan, Y., Smith, J., Van Heyningen, V., Rubenstein, J. L., and Livesey, F. J. (2009). The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis. PLoS Genet. 5, e1000511. doi:10.1371/journal.pgen.1000511
92. Sanz, E., Alvarez-Mon, M., Martinez, A. C., and De La Hera, A. (2003). Human cord blood CD34+Pax-5+ B-cell progenitors: single-cell analyses of their gene expression profiles. Blood 101, 3424-3430.
93. Scholl, F. A., Kamarashev, J., Murmann, O. V., Geertsen, R., Dummer, R., and Schafer, B. W. (2001). PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res. 61, 823-826.
94. Silberstein, G. B., Dressler, G. R., and Van Horn, K. (2002). Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth. Oncogene 21, 1009-1016.
95. Sivak, J. M., Mohan, R., Rinehart, W. B., Xu, P. X., Maas, R. L., and Fini, M. E. (2000). Pax-6 expression and activity are induced in the reepithelializing cornea and control activity of the transcriptional promoter for matrix metalloproteinase gelatinase B. Dev. Biol. 222, 41-54.
96. Stoykova, A., and Gruss, P. (1994). Roles of Pax-genes in developing and adult brain as suggested by expression patterns. J. Neurosci. 14, 1395-1412.
97. Suda, N., Ogawa, T., Kojima, T., Saito, C., and Moriyama, K. (2011). Non-syndromic oligodontia with a novel mutation of PAX9. J. Dent. Res. 90, 382-386.
98. Thomas, T., Nowka, K., Lan, L., and Derwahl, M. (2006). Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid 16, 537-544.
99. Tong, G. X., Chiriboga, L., Hamele-Bena, D., and Borczuk, A. C. (2007). Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin? Mod. Pathol. 20, 856-863.
100. Tong, G. X., Melamed, J., Mansukhani, M., Memeo, L., Hernandez, O., Deng, F. M., Chiriboga, L., and Waisman, J. (2006). PAX2: a reliable marker for nephrogenic adenoma. Mod. Pathol. 19, 356-363.
101. Tong, G. X., Memeo, L., Colarossi, C., Hamele-Bena, D., Magi-Galluzzi, C., Zhou, M., Lagana, S. M., Harik, L., Oliver-Krasinski, J. M., Mansukhani, M., Falcone, L., Hibshoosh, H., and O'Toole, K. (2011). PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract. Am. J. Surg. Pathol. 35, 1473-1483.
102. Tong, G. X., Yu, W. M., Beaubier, N. T., Weeden, E. M., Hamele-Bena, D., Mansukhani, M. M., and O'Toole, K. M. (2009). Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod. Pathol. 22, 1218-1227.
103. Urbanek, P., Wang, Z. Q., Fetka, I., Wagner, E. F., and Busslinger, M. (1994). Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901-912.
104. Vidal, L. J., Perry, J. K., Vouyovitch, C. M., Pandey, V., Brunet-Dunand, S. E., Mertani, H. C., Liu, D. X., and Lobie, P. E. (2010). PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells. Mol. Cancer Res. 8, 444-456.
105. Vorobyov, E., and Horst, J. (2006). Getting the proto-Pax by the tail. J. Mol. Evol. 63, 153-164.
106. Wallin, J., Eibel, H., Neubuser, A., Wilting, J., Koseki, H., and Balling, R. (1996). Pax1 is expressed during development of the thymus epithelium and is required for normal T-cell maturation. Development 122, 23-30.
107. Wang, Q., Fang, W. H., Krupinski, J., Kumar, S., Slevin, M., and Kumar, P. (2008). Pax genes in embryogenesis and oncogenesis. J. Cell. Mol. Med. 12, 2281-2294.
108. Watanabe, A., Takeda, K., Ploplis, B., and Tachibana, M. (1998). Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat. Genet. 18, 283-286.
109. Wu, H., Chen, Y., Liang, J., Shi, B., Wu, G., Zhang, Y., Wang, D., Li, R., Yi, X., Zhang, H., Sun, L., and Shang, Y. (2005). Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438, 981-987.
110. Zannini, M., Francis-Lang, H., Plachov, D., and Di Lauro, R. (1992). Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters. Mol. Cell. Biol. 12, 4230-4241.
111. Zhang, X., Huang, C. T., Chen, J., Pankratz, M. T., Xi, J., Li, J., Yang, Y., Lavaute, T. M., Li, X. J., Ayala, M., Bondarenko, G. I., Du, Z. W., Jin, Y., Golos, T. G., and Zhang, S. C. (2010). Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell 7, 90-100.
112. Zhou, Y. H., Hu, Y., Mayes, D., Siegel, E., Kim, J. G., Mathews, M. S., Hsu, N., Eskander, D., Yu, O., Tromberg, B. J., and Linskey, M. E. (2010). PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A. J. Neurooncol. 96, 191-200.
113. Zhou, Y. H., Wu, X., Tan, F., Shi, Y. X., Glass, T., Liu, T. J., Wathen, K., Hess, K. R., Gumin, J., Lang, F., and Yung, W. K. (2005). PAX6 suppresses growth of human glioblastoma cells. J. Neurooncol. 71, 223-229.
114. Zong, X., Yang, H., Yu, Y., Zou, D., Ling, Z., He, X., and Meng, X. (2011). Possible role of Pax-6 in promoting breast cancer cell proliferation and tumorigenesis. BMB Rep. 44, 595-600.